Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Other Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02280317
What this trial is testing

Dose Finding Safety Study of VAL201 in Cancer Patients

Who this might be right for
Stage III Prostate CarcinomaStage IV Prostate Carcinoma
ValiRx Plc 12
Not applicableStudy completedNCT01493817
What this trial is testing

Biomarkers in Samples From Younger Patients With Wilms Tumor

Who this might be right for
Wilms Tumor and Other Childhood Kidney Tumors
Children's Oncology Group 30
Early research (Phase 1)Study completedNCT00004016
What this trial is testing

Interferon Gamma in Treating Patients With Recurrent or Metastatic Melanoma or Other Solid Tumors

Who this might be right for
Melanoma (Skin)Unspecified Adult Solid Tumor, Protocol Specific
University of Rochester
Early research (Phase 1)Study completedNCT04572295
What this trial is testing

E7090 as Monotherapy and in Combination With Other Anticancer Agents in Participants With Estrogen Receptor Positive (ER+) and Human Epidermal Growth Receptor 2 Negative (HER2-) Recurrent/Metastatic Breast Cancer

Who this might be right for
Breast Neoplasms
Eisai Co., Ltd. 51
Early research (Phase 1)Ended earlyNCT02687230
What this trial is testing

Phase 1 Imaging Study of 89Zr-DFO-HuMab-5B1 With HuMab-5B1

Who this might be right for
Pancreatic CarcinomaTumors That Express CA19-9
BioNTech Research & Development, Inc. 15
Not applicableUnknownNCT04921553
What this trial is testing

Real Word European Registry of NTRK Fusions and Other Rare Actionable Fusions (TRacKING)

Who this might be right for
CancerCancer MetastaticNTRK Gene Fusion Overexpression+13 more
Centre Leon Berard 500
Early research (Phase 1)Ended earlyNCT00376519
What this trial is testing

Umbilical Cord Blood T-Regulatory Cell Infusion Followed by Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Leukemia or Other Hematologic Diseases

Who this might be right for
Graft Versus Host DiseaseLeukemiaLymphoma+3 more
Masonic Cancer Center, University of Minnesota 3
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07811297
What this trial is testing

Catequentinib Hydrochloride (AL3818) in Endometrial, LGSOC, STS or GBM Cancers

Who this might be right for
Endometrial NeoplasmsOvarian NeoplasmsSoft Tissue Sarcoma (STS)+1 more
Advenchen Pharmaceuticals, LLC. 138
Testing effectiveness (Phase 2)UnknownNCT00927797
What this trial is testing

Interventional Study on Pentostatin, Cyclophosphamide and Rituximab in Indolent B-Cell Non-Hodgkin-Lymphoma (B-NHL)

Who this might be right for
Immunocytoma/Morbus WaldenströmB-Cell Non-Hodgkin's LymphomaB-Cell Chronic Lymphocytic Leukemia
Heidelberg University 185
Not applicableStudy completedNCT02546479
What this trial is testing

Follow-Up Study of People Treated for Scoliosis

Who this might be right for
Breast and Other Cancer Incidence and MortalityAll Cause MortalityCirculatory Disease Mortality+1 more
National Cancer Institute (NCI) 5,573
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07767474
What this trial is testing

Evaluate ATX-898 in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Antares Therapeutics, Inc 343
Testing effectiveness (Phase 2)Study completedNCT02332980
What this trial is testing

Pembrolizumab Alone or With Idelalisib or Ibrutinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Other Low-Grade B-Cell Non-Hodgkin Lymphomas

Who this might be right for
Recurrent B-Cell Non-Hodgkin LymphomaRecurrent Chronic Lymphocytic LeukemiaRecurrent Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue+20 more
Mayo Clinic 65
Early research (Phase 1)Ended earlyNCT02097225
What this trial is testing

Onalespib, Dabrafenib, and Trametinib in Treating Patients With BRAF-Mutant Melanoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery

Who this might be right for
BRAF V600E Mutation PresentBRAF V600K Mutation PresentMetastatic Malignant Solid Neoplasm+7 more
National Cancer Institute (NCI) 22
Early research (Phase 1)Not Yet RecruitingNCT06699576
What this trial is testing

ARTEMIS-103: Phase 1b Study of HS-20093 Combinations in Patients with Bone and Soft Tissue Sarcoma.

Who this might be right for
OsteosarcomaSoft Tissue Sarcoma (STS)
Hansoh BioMedical R&D Company 448
Testing effectiveness (Phase 2)WithdrawnNCT06233903
What this trial is testing

18F-mFBG Expression in Neural Crest Tumors and Organs Innervated by the Sympathetic Nervous System

Who this might be right for
NeuroblastomaPheochromocytomaParaganglioma
Innervate Radiopharmaceuticals LLC (Formerly: Illumina Radiopharmaceuticals LLC)
Not applicableStudy completedNCT00419016
What this trial is testing

Association Between Schizophrenia and Cancer

Who this might be right for
SchizophreniaCancer
Sheba Medical Center
Not applicableStudy completedNCT00996047
What this trial is testing

S9007, Study of Bone Marrow and Blood Samples From Patients With Leukemia or Other Hematopoietic Cancers

Who this might be right for
LeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasms
SWOG Cancer Research Network 3,341
Testing effectiveness (Phase 2)Study completedNCT01125800
What this trial is testing

A Phase I Dose Finding and Safety Study of Oral LDE225 in Children and a Phase II Portion to Assess Preliminary Efficacy in Recurrent or Refractory MB

Who this might be right for
MedulloblastomaRhabdomyosarcomaNeuroblastoma+3 more
Novartis Pharmaceuticals 76
Early research (Phase 1)Study completedNCT02900716
What this trial is testing

Safety Study of BTK Inhibitor, DTRMWXHS-12, Used Singly or in Combination, in CLL and B-cell Lymphomas

Who this might be right for
Chronic Lymphocytic LeukemiaB-Cell Lymphoma
Zhejiang DTRM Biopharma 48
Testing effectiveness (Phase 2)Ended earlyNCT02685111
What this trial is testing

Intermittent G-CSF in Patients With Breast Cancer Receiving Adjuvant Docetaxel, Doxorubicin, and Cyclophosphamide (TAC)

Who this might be right for
Breast CancerNeutropeniaFebrile Neutropenia
Asan Medical Center 22
Next Page